30,000
Participants
Start Date
February 21, 2018
Primary Completion Date
October 30, 2024
Study Completion Date
October 30, 2025
Vi-Typhoid Conjugate Vaccine (Vi-TCV)
Single 0.5-ml intramuscular injection
Meningococcal A Conjugate Vaccine (MCV-A)
Single intramuscular injection. Children 9-11 months will receive a 5µg/0.5ml dose. Children 12 months and older will receive a 10µg/0.5 ml dose.
Malawi Liverpool Wellcome Trust Clinical Research Programme, Queen Elizabeth Central Hospital College of Medicine, Blantyre
Bill and Melinda Gates Foundation
OTHER
Malawi-Liverpool-Wellcome Trust Clinical Research Programme
OTHER
University College, London
OTHER
University of Malawi
OTHER
University of Maryland, Baltimore
OTHER